Canopy Cancer Collective Registry for GI Cancers

This is an observational study, called a registry, that collects information about people with gastrointestinal (GI) cancers, including pancreatic and colorectal cancer. The study aims to gather comprehensive data on your past medical history and future health experiences. This information will help researchers better understand these cancers, find ways to improve patient care, and identify best practices. The goal is to enroll 100,000 participants. You may be able to join if you are 18 or older and have a confirmed GI cancer diagnosis. This registry does not involve any specific treatments or interventions.

Study design
This is an observational registry study, not a treatment trial. It aims to collect data from 100,000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 120 months (10 years) to measure the number of people enrolled in the registry.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07605702

The Canopy Cancer Collective Clinical Registry Protocol

Not Yet Recruiting
Not specifiedAges 18+Observational
Canopy Cancer Collective, LLC
~100,000 participants
Updated 2026-05-26 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants enrolled in registry
Measured over Up to 120 months
Gastrointestinal Neoplasms
Pancreatic Cancer
Colorectal Cancer
GI Cancers
PDAC - Pancreatic Ductal Adenocarcinoma
PDAC
GI Cancer
10 sites across 7 states
New York3
Texas2
California1
Florida1
Maryland1
Ohio1
Washington1
  • Michael Pishvaian, MD, PhD · STUDY_CHAIR · Johns Hopkins University

Opens a ready-to-send draft in your own email app — review before sending.

  • Number of participants enrolled in registryUp to 120 months

    Count of participants enrolled in the Canopy Cancer Collective GI cancer registry (prospective + retrospective).